DURECT (DRRX)
(Delayed Data from NSDQ)
$0.92 USD
+0.03 (3.67%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.91 -0.01 (-0.64%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for DURECT Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9 | 19 | 14 | 30 | 30 |
Cost Of Goods | 2 | 2 | 2 | 1 | 4 |
Gross Profit | 7 | 18 | 12 | 29 | 25 |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 53 | 46 | 41 | 45 |
Income After Depreciation & Amortization | -37 | -35 | -34 | -13 | -19 |
Non-Operating Income | 12 | 2 | 0 | 1 | 1 |
Interest Expense | 3 | 2 | 2 | 2 | 3 |
Pretax Income | -28 | -35 | -36 | -14 | -21 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -28 | -35 | -36 | -14 | -21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 14 | 0 |
Net Income (GAAP) | -28 | -35 | -36 | -1 | -21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -36 | -34 | -34 | -12 | -18 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 1 | 0 | 1 |
Income After Depreciation & Amortization | -37 | -35 | -34 | -13 | -19 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 26.52 | 22.78 | 22.51 | 19.95 | 17.80 |
Diluted EPS Before Non-Recurring Items | -1.57 | -1.55 | -1.60 | -0.70 | -1.20 |
Diluted Net EPS (GAAP) | -1.20 | -1.55 | -1.60 | 0.00 | -1.20 |
Fiscal Year end for DURECT Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2.67 | 1.74 | 2.08 | 2.05 |
Cost Of Goods | NA | 0.66 | 0.31 | 0.36 | 0.39 |
Gross Profit | NA | 2.01 | 1.43 | 1.72 | 1.67 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8.26 | 10.99 | 11.78 | 12.69 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.25 | -9.56 | -10.06 | -11.02 |
Non-Operating Income | NA | 5.43 | 7.24 | -0.38 | -0.24 |
Interest Expense | NA | 0.62 | 0.70 | 0.75 | 0.73 |
Pretax Income | NA | -1.44 | -3.02 | -11.18 | -11.99 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.44 | -3.02 | -11.18 | -11.99 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.44 | -3.02 | -11.18 | -11.99 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 30.05 | 27.21 | 24.51 | 23.94 |
Diluted EPS Before Non-Recurring Items | NA | -0.27 | -0.40 | -0.46 | -0.52 |
Diluted Net EPS (GAAP) | NA | -0.11 | -0.11 | -0.46 | -0.52 |